Bionano Genomics Inc (BNGO)
0.2505
-0.01
(-2.11%)
USD |
NASDAQ |
Nov 15, 09:42
Bionano Genomics Cash from Operations (Quarterly): -20.98M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -20.98M |
| March 31, 2024 | -28.13M |
| December 31, 2023 | -29.78M |
| September 30, 2023 | -26.29M |
| June 30, 2023 | -36.70M |
| March 31, 2023 | -32.41M |
| December 31, 2022 | -34.52M |
| September 30, 2022 | -29.47M |
| June 30, 2022 | -28.33M |
| March 31, 2022 | -32.49M |
| December 31, 2021 | -25.62M |
| September 30, 2021 | -19.98M |
| June 30, 2021 | -12.42M |
| March 31, 2021 | -13.90M |
| December 31, 2020 | -12.10M |
| Date | Value |
|---|---|
| September 30, 2020 | -10.96M |
| June 30, 2020 | -7.218M |
| March 31, 2020 | -8.032M |
| December 31, 2019 | -9.382M |
| September 30, 2019 | -7.28M |
| June 30, 2019 | -6.316M |
| March 31, 2019 | -6.552M |
| December 31, 2018 | -4.090M |
| September 30, 2018 | -6.100M |
| June 30, 2018 | -2.966M |
| March 31, 2018 | -6.788M |
| December 31, 2017 | -2.809M |
| September 30, 2017 | -5.655M |
| June 30, 2017 | -4.988M |
| March 31, 2017 | -7.366M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-36.70M
Minimum
Jun 2023
-7.218M
Maximum
Jun 2020
-22.04M
Average
-25.62M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| Revvity Inc | 147.88M |
| Bruker Corp | 38.40M |
| Azenta Inc | 1.791M |
| Harvard Bioscience Inc | -0.842M |
| Akoya Biosciences Inc | -11.04M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 28.63M |
| Cash from Financing (Quarterly) | -1.978M |
| Free Cash Flow | -106.10M |
| Free Cash Flow Per Share (Quarterly) | -3.115 |
| Free Cash Flow to Equity (Quarterly) | -11.33M |
| Free Cash Flow to Firm (Quarterly) | -21.06M |
| Free Cash Flow Yield | -1.26K% |